Bone health in cancer: ESMO Clinical Practice Guidelines

被引：289

作者：

Coleman, R. ^{[1
]}

Hadji, P. ^{[2
,3
]}

Body, J-J ^{[4
]}

Santini, D. ^{[5
]}

Chow, E. ^{[6
]}

Terpos, E. ^{[7
]}

Oudard, S. ^{[8
]}

Bruland, O. ^{[9
,10
]}

Flamen, P. ^{[11
]}

Kurth, A. ^{[12
,13
]}

Van Poznak, C. ^{[14
]}

Aapro, M. ^{[15
]}

Jordan, K. ^{[16
]}

机构：

[1] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England

[2] Frankfurt Ctr Bone Hlth, Frankfurt, Germany

[3] Philipps Univ Marburg, Marburg, Germany

[4] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium

[5] Univ Campus Biomed, Med Oncol Dept, Rome, Italy

[6] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada

[7] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece

[8] Paris Descartes Univ, Georges Pompidou Hosp, Dept Med Oncol, Paris, France

[9] Univ Oslo, Inst Clin Med, Oslo, Norway

[10] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway

[11] Univ Libre Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium

[12] Community Clin Middle Rhine, Dept Orthopaed & Trauma Surg, Campus Kemperhof, Koblenz, Germany

[13] Univ Med Mainz, Major Teaching Hosp, Mainz, Germany

[14] Univ Michigan, Ann Arbor, MI 48109 USA

[15] Genolier Canc Ctr, Genolier, Switzerland

[16] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 12期

关键词：

bone metastases; cancer treatment-induced bone loss; bone-targeted agents; Clinical Practice Guidelines; diagnosis; treatment; follow-up; EARLY BREAST-CANCER; ZOLEDRONIC ACID; MULTIPLE-MYELOMA; DOUBLE-BLIND; SOLID TUMORS; OPEN-LABEL; DENOSUMAB; METASTASES; PHASE-3; SURVIVAL;

D O I：

10.1016/j.annonc.2020.07.019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1650 / 1663

页数：14

共 50 条

[31] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Horwich, A.
Parker, C.
de Reijke, T.
Kataja, V.
ANNALS OF ONCOLOGY, 2013, 24 : 106 - 114
[32] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glimelius, B.
Pahlman, L.
Cervantes, A.
ANNALS OF ONCOLOGY, 2010, 21 : v82 - v86
[33] Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bellmunt, J.
Orsola, A.
Wiegel, T.
Guix, M.
De Santis, M.
Kataja, V.
ANNALS OF ONCOLOGY, 2011, 22 : vi45 - vi49
[34] Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Berruti, A.
Baudin, E.
Gelderblom, H.
Haak, H. R.
Porpiglia, F.
Fassnacht, M.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2012, 23 : 131 - 138
[35] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pacini, F.
Castagna, M. G.
Brilli, L.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2012, 23 : 110 - 119
[36] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Haie-Meder, C.
Morice, P.
Castiglione, M.
ANNALS OF ONCOLOGY, 2010, 21 : v37 - v40
[37] Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cascinu, S.
Falconi, M.
Valentini, V.
Jelic, S.
ANNALS OF ONCOLOGY, 2010, 21 : v55 - v58
[38] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Filetti, S.
Durante, C.
Hartl, D.
Leboulleux, S.
Locati, L. D.
Newbold, K.
Papotti, M. G.
Berruti, A.
ANNALS OF ONCOLOGY, 2019, 30 (12) : 1856 - 1883
[39] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Marth, C.
Landoni, F.
Mahner, S.
McCormack, M.
Gonzalez-Martin, A.
Colombo, N.
ANNALS OF ONCOLOGY, 2017, 28 : 72 - 83
[40] Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Rao, S.
Guren, M. G.
Khan, K.
Brown, G.
Renehan, A. G.
Steigen, S. E.
Deutsch, E.
Martinelli, E.
Arnold, D.
ANNALS OF ONCOLOGY, 2021, 32 (09) : 1087 - 1100

← 1 2 3 4 5 →